Bayer reported 7.43B in Gross Profit on Sales for its fourth fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Gross Profit On Sales Change
Akzo Nobel AKZA:NA 909M 18M
Alcon AG ALC:SW 1.21B 12M
Amarin AMRN:US $ 72.39M 41.46M
Arkema AKE:FP € 531M 41M
AstraZeneca AZN:LN 8.94B 2.9B
BASF BAS:GR 4.91B 174M
Bayer BAYN:GR 7.43B 1.54B
Corteva Inc CTVA:US $ 1.88B 630M
Covestro 1COV:GR 1B 233M
Fresenius FRE:GR € 2712M 189M
Fresenius Medical Care FME:GR € 1319M 52M
Givaudan GIVN:VX 1.38B 105M
GlaxoSmithKline GSK:LN 6.14B 283M
GRIFOLS GRF:SM € 580.8M 47.47M
H. Lundbeck A/S LUN:DC 3.53B 474M
Hikma Pharmaceutical HIK:LN 685M 69M
Johnson Matthey JMAT:LN 548M 79M
Linde LIN:GR 3.37B 71M
Lonza Group LONN:SW 1.07B 24M
Merck MRK:GR € 3211M 43M
Novartis NOVN:VX 9.52B 3M
Nutrien Ltd NTR:CN C$ 3.26B 51M
Philips PHIA:NA € 1918M 56M
Ppg Industries PPG:US $ 1610M 112M
SAP SAP:GR 5.89B 943M
Solvay SOLB:BB € 695M 53M
Umicore UMI:BB 641.25M 274.45M